Publication Date
| In 2025 | 0 |
| Since 2024 | 1 |
| Since 2021 (last 5 years) | 3 |
| Since 2016 (last 10 years) | 3 |
| Since 2006 (last 20 years) | 3 |
Descriptor
| Data Analysis | 3 |
| Evaluation Methods | 3 |
| Medical Research | 2 |
| Comparative Analysis | 1 |
| Computer Software | 1 |
| Correlation | 1 |
| Cost Effectiveness | 1 |
| Data | 1 |
| Databases | 1 |
| Decision Making | 1 |
| Drug Therapy | 1 |
| More ▼ | |
Source
| Research Synthesis Methods | 3 |
Author
| Anja Jacobs | 1 |
| Boon, Michele Hilton | 1 |
| Katja Matthias | 1 |
| Kieser, Meinhard | 1 |
| Mirjam Jenny | 1 |
| Proctor, Tanja | 1 |
| Robert C. Lorenz | 1 |
| Seide, Svenja | 1 |
| Thomson, Hilary | 1 |
| Zimmermann, Samuel | 1 |
Publication Type
| Journal Articles | 3 |
| Reports - Research | 3 |
| Information Analyses | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkRobert C. Lorenz; Mirjam Jenny; Anja Jacobs; Katja Matthias – Research Synthesis Methods, 2024
Conducting high-quality overviews of reviews (OoR) is time-consuming. Because the quality of systematic reviews (SRs) varies, it is necessary to critically appraise SRs when conducting an OoR. A well-established appraisal tool is A Measurement Tool to Assess Systematic Reviews (AMSTAR) 2, which takes about 15-32 min per application. To save time,…
Descriptors: Decision Making, Time Management, Evaluation Methods, Quality Assurance
Boon, Michele Hilton; Thomson, Hilary – Research Synthesis Methods, 2021
Effect direction (evidence to indicate improvement, deterioration, or no change in an outcome) can be used as a standardized metric which enables the synthesis of diverse effect measures in systematic reviews. The effect direction (ED) plot was developed to support the synthesis and visualization of effect direction data. Methods for the ED plot…
Descriptors: Visualization, Data Analysis, Measurement Techniques, Guidance
Proctor, Tanja; Zimmermann, Samuel; Seide, Svenja; Kieser, Meinhard – Research Synthesis Methods, 2022
During drug development, a biomarker is sometimes identified as separating a patient population into those with more and those with less benefit from evaluated treatments. Consequently, later studies might be targeted, while earlier ones are performed in mixed patient populations. This poses a challenge in evidence synthesis, especially if only…
Descriptors: Comparative Analysis, Meta Analysis, Patients, Medical Research
